Positioning siponimod and the post-treatment gap: the unmet needs of SPMS patients in Italian real-world practice

Background: Siponimod, a selective sphingosine-1-phosphate receptor modulator was approved for patients with Secondary progressive Multiple Sclerosis (SPMS) with ongoing disease activity. However, its real-world positioning and management after discontinuation remain challenging. Objectives: To eval...

全面介紹

書目詳細資料

Principais autores:	Aurora Zanghì, Giovanna Borriello, Matteo Foschi, Assunta Bianco, Elisabetta Signoriello, Maria Cellerino, Paola Sofia Di Filippo, Francesco Baldisseri, Giuseppe Romano, Alessandra Cicia, Giacomo Lus, Matilde Inglese, Massimiliano Mirabella, Carlo Avolio, Emanuele D’Amico
格式:	Artigo
語言:	Inglês
出版:	SAGE Publishing 2026-02-01
叢編:	Therapeutic Advances in Neurological Disorders
在線閱讀:	https://doi.org/10.1177/17562864251399560
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!